1730-1731 / 1778
CONCLUSION
•
In the present study the results obtained with the use of MRI-GBT in
all the women with cervical cancer are comparable to those of the
most important multicentre studies reported to date, with scarce,
albeit manageable, late toxicity.
•
The future is leading in the direction of the EMBRACE II study which is
aimed at reducing toxicity in women showing good response after
radiochemotherapy and intensification of brachytherapy treatment,
especially with interstitial brachytherapy in order to improve local
control and survival in patients with advanced tumours and poor
initial response.